MY PHARMA EDITIONS – The Life Sciences Acceleration Alliance (LSAA) has chosen to hold its launch conference at the HealthTech Innovations Day, in front of life sciences industrialists, scientists and investors. This new not-for-profit association will be led by HealthTech professional organisations and investment funds. Its aim will be to support public policies that will strengthen the European HealthTech ecosystem and stimulate innovation. Last year, for example, only €4.3 billion was invested in the life sciences sector in Europe, compared with more than €30 billion in the United States. Headquartered in Germany, LSAA will work on a European scale with offices in France and the UK.